Mondelez International (MDLZ) closed at a fresh 52-week high of $66.14 on November 2, 2026, up 1.8% on the day and 5.0% over the past five sessions, after a strong Q3 earnings beat and a majority stake in Undercover Snacks. The stock is now 6.1% below the mean analyst target of $70.41, and the weekly trend remains up with price above its 40-week average. The balance of evidence leans positive for the next 2–6 weeks, but conviction is only medium: the stock leads the S&P 500 but lags its sector, and the math from a breakout above $70 does not reach the 3-to-1 reward-to-risk that would make it compelling.
Why it matters
MDLZ reported Q3 earnings on October 29, 2026, beating EPS estimates by $0.08 at $0.78, though revenue narrowly missed, according to Seeking Alpha. The beat was driven by volume and mix growth accelerating to 1.8%, the strongest since Q3 2023, and gross margin expanding by 380 basis points, per Investing.com. The market rewarded the stock with a 5.0% gain over five days, while the S&P 500 fell 1.0% and the consumer staples sector (XLP) rose 3.2% — so MDLZ outperformed its sector by 1.9 percentage points, a sign the move was stock-specific, not just a defensive rotation.
The stock's reaction also reflects a broader market shift. On October 30, tech stocks sold off sharply — Intel plunged 28.6%, its worst drop since 1974, and the S&P 500 had its worst day since June — while investors rotated into defensive names like MDLZ and Colgate-Palmolive, as Investor's Business Daily noted. That backdrop helped MDLZ, but the stock's own earnings and the Undercover Snacks deal, announced October 30, gave it a fundamental catalyst. The acquisition of a majority stake in the better-for-you quinoa crisp maker aligns with MDLZ's strategy to expand into healthier snacks, though terms were undisclosed, per PR Newswire.
The debate among analysts is constructive but not euphoric. Investing.com reported Freedom Broker upgraded MDLZ to buy from hold with a $71 target, citing organic net revenue growth of 2.1% and adjusted operating income up 17.0%. Stifel raised its target to $74, maintaining a buy, per Investing.com. The consensus is buy from 22 analysts, with a mean target of $70.41, a low of $55, and a high of $77 — the stock at $66.14 sits 6.1% below the mean, leaving room but not a huge gap. The bull case rests on volume growth and margin expansion; the bear case would point to cocoa prices, which have surged to around $5,600 per metric ton from $2,200–$2,550 in 2022, pressuring input costs, as Morningstar reported.
There is also a legal overhang: on November 2, The Guardian reported MDLZ sent a legal letter to vegan chocolate brand Moo Free demanding it remove its White Choccy Snowballs, claiming trademark infringement over Cadbury Snow Balls. This is a minor, routine dispute, unlikely to move the stock, but it shows the company is actively defending its brands. The real question is whether the earnings beat and the Undercover deal can sustain the stock's momentum, or whether the market has already priced in the good news.
What the evidence says
The long-term thesis is intact. MDLZ is above its 40-week average, and the daily trend runs with the weekly uptrend — the trend alignment is positive. The stock is up 22.9% year-to-date, versus 11.2% for the S&P 500, and up 7.8% over six months. It is leading the S&P 500 by 8.3 percentage points over 50 days and by 5.1 over 200 days, though it lags its sector (XLP) by 0.2 percentage points over 50 days — a small crack in the relative strength story. The stock is in a clear uptrend, having just made a new 52-week high, and the 50-day average ($61.83) and 200-day average ($60.43) are both below price, providing a solid base.
For the next 2–6 weeks, the balance of evidence leans positive, but conviction is medium, not high. The reasons: the daily trend aligns with the weekly uptrend, the stock leads the S&P 500 over 50 days, and it just broke to a new high on strong earnings. However, the lag versus XLP over 50 days is a warning that the sector itself is doing the heavy lifting, and the stock's volume on the breakout day was 45.5% below its 20-day average — a new high on light volume is less convincing. The strongest case against the positive reading is that the stock is extended: RSI is 65.55, near overbought, and the 5-day gain of 5.0% may have pulled forward demand. A pullback to the 65.39 swing zone would be healthy, but a weekly close below 64.18 would end the trend. That risk is real, but it does not tip the balance because the earnings beat and the sector tailwind are concrete, while the pullback is speculative.
Levels that matter
The structure holds above $65.39, a swing zone that has acted as support. A daily close below that level would be the first crack, and a weekly close below $64.18 — the next swing zone — would end the uptrend, as it would put price below the 50-day average ($61.83) and toward the 200-day ($60.43). The stock closed at $66.14, just 1.1% above the first support, so the buffer is thin. The 52-week high is $66.14, and the low is $51.51, so the stock is 28.4% off the low and at the high.
The breakout level is a daily close above $70.00 (a round number) on volume above its 20-day average. From $70.00, the first target is $80.00 (round), which gives a reward-to-risk of 2.0 to 1 against a stop at $65.02 (the swing zone of $65.39 minus a quarter of the ATR of $1.49). That math does not reach 3 to 1 — the threshold that makes a breakout worth the risk. To get to 3 to 1, the target would need to be higher (e.g., $85) or the stop tighter, but the stop is already tight at $65.02. So the map says: a breakout above $70 is positive, but the reward does not justify the risk at current levels.
What would change the picture
The picture would change on a weekly close below $64.18, the swing zone that marks the end of the uptrend. That would put the stock below the 50-day average and signal that the earnings-driven rally has failed. The one non-price fact that would change the picture is a significant deterioration in cocoa costs or a broader consumer slowdown that hits volume growth — the earnings beat was built on volume and mix, so a reversal there would undermine the thesis.
What to watch
- Next earnings: already reported October 29, 2026; the next report is likely late January 2027. The number that matters is volume and mix growth — it accelerated to 1.8%, and a slowdown would be the first sign of trouble.
- Sector events: cocoa prices and any major moves in XLP, since MDLZ has lagged its sector over 50 days; a sector pullback would likely drag MDLZ down with it.
- Valuation: the stock trades 6.1% below the mean analyst target of $70.41, with a consensus buy from 22 analysts. A move to the mean would be a 6% gain, but the high target of $77 implies 16% upside — the range is wide, reflecting uncertainty.